35Pharma is a Biotech company. It has raised $53M in total funding. Latest round: Series C.
35Pharma funding overview
35Pharma is a Biotech company. 35Pharma has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in December 2024. The round record for 35Pharma runs through 2024; nothing later has been disclosed. Investors on record include Frazier Life Sciences, Vivo Capital, Janus Henderson Investors, Deep Track Capital, Paradigm BioCapital Advisors, Columbia Threadneedle and 4 others. 10 distinct backers are named across the disclosed rounds.
35Pharma at a glance
Total raised
$53M
Latest round
Series C
Latest round date
December 2024
Industry
Biotech
Notable investors
Frazier Life Sciences, Vivo Capital, Janus Henderson Investors, Deep Track Capital, Paradigm BioCapital Advisors, Columbia Threadneedle, VenBio, Surveyor Capital
Frequently asked about 35Pharma funding
How much has 35Pharma raised?
35Pharma has raised $53M in total disclosed funding across the rounds on record.
Who has invested in 35Pharma?
Frazier Life Sciences, Vivo Capital, Janus Henderson Investors, Deep Track Capital, Paradigm BioCapital Advisors, Columbia Threadneedle are named among the investors backing 35Pharma.
What was the latest 35Pharma funding round?
The most recent disclosed round is a Series C, announced in December 2024.
Where is 35Pharma based?
No headquarters location is disclosed for 35Pharma.
What sector does 35Pharma operate in?
35Pharma is tracked under Biotech, with $53M in disclosed funding.
When did 35Pharma last raise?
The last disclosed 35Pharma round closed in December 2024 at Series C.
Every 35Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies at a similar stage.
